Free Trial

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Purchased by Entropy Technologies LP

DENTSPLY SIRONA logo with Medical background

Key Points

  • Entropy Technologies LP increased its stake in DENTSPLY SIRONA Inc. by 116.7%, acquiring an additional 38,783 shares and bringing its total holdings to 72,002 shares valued at approximately $1,076,000.
  • Several institutional investors have significantly raised their positions in DENTSPLY SIRONA, including AQR Capital Management, which increased its stake by 245.1% in the fourth quarter.
  • DENTSPLY SIRONA's stock has seen a price decline, with analysts adjusting target prices downwards, and the current consensus rating is a "Hold" with a price target of $18.64.
  • Five stocks to consider instead of DENTSPLY SIRONA.

Entropy Technologies LP grew its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 116.7% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 72,002 shares of the medical instruments supplier's stock after purchasing an additional 38,783 shares during the quarter. Entropy Technologies LP's holdings in DENTSPLY SIRONA were worth $1,076,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in XRAY. LPL Financial LLC boosted its stake in shares of DENTSPLY SIRONA by 52.2% during the fourth quarter. LPL Financial LLC now owns 115,108 shares of the medical instruments supplier's stock valued at $2,185,000 after purchasing an additional 39,498 shares during the period. Envestnet Asset Management Inc. boosted its stake in shares of DENTSPLY SIRONA by 18.6% during the fourth quarter. Envestnet Asset Management Inc. now owns 453,801 shares of the medical instruments supplier's stock valued at $8,613,000 after purchasing an additional 71,213 shares during the period. Cerity Partners LLC boosted its stake in shares of DENTSPLY SIRONA by 268.5% during the fourth quarter. Cerity Partners LLC now owns 65,588 shares of the medical instruments supplier's stock valued at $1,294,000 after purchasing an additional 47,788 shares during the period. Bank of Nova Scotia purchased a new stake in shares of DENTSPLY SIRONA during the fourth quarter valued at $357,000. Finally, Treasurer of the State of North Carolina boosted its stake in shares of DENTSPLY SIRONA by 0.6% during the fourth quarter. Treasurer of the State of North Carolina now owns 88,854 shares of the medical instruments supplier's stock valued at $1,686,000 after purchasing an additional 560 shares during the period. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Stock Down 0.1%

XRAY traded down $0.02 during trading on Friday, hitting $13.85. The stock had a trading volume of 2,967,785 shares, compared to its average volume of 4,518,758. The company has a market capitalization of $2.76 billion, a PE ratio of -2.92, a PEG ratio of 0.86 and a beta of 0.94. DENTSPLY SIRONA Inc. has a twelve month low of $12.16 and a twelve month high of $27.48. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.11 and a current ratio of 1.69. The stock has a 50 day simple moving average of $15.46 and a two-hundred day simple moving average of $15.71.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.50 by $0.02. The company had revenue of $936.00 million during the quarter, compared to the consensus estimate of $929.67 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. DENTSPLY SIRONA's revenue was down 4.9% compared to the same quarter last year. During the same period last year, the firm earned $0.49 earnings per share. On average, research analysts predict that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 10th. Stockholders of record on Friday, September 26th will be issued a dividend of $0.16 per share. The ex-dividend date is Friday, September 26th. This represents a $0.64 annualized dividend and a dividend yield of 4.6%. DENTSPLY SIRONA's dividend payout ratio is -13.50%.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on XRAY. Stifel Nicolaus decreased their price objective on DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating for the company in a report on Friday, August 8th. UBS Group cut their target price on shares of DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating on the stock in a research report on Friday, August 8th. Wall Street Zen downgraded shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a research report on Monday, July 21st. Finally, Piper Sandler cut their target price on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 30th. Twelve equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, DENTSPLY SIRONA currently has a consensus rating of "Hold" and a consensus price target of $18.64.

View Our Latest Stock Report on DENTSPLY SIRONA

About DENTSPLY SIRONA

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Featured Articles

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Should You Invest $1,000 in DENTSPLY SIRONA Right Now?

Before you consider DENTSPLY SIRONA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.

While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.